Karyopharm Therapeutics | KPTI - 流动负债

金融业

USD 0.07

USD 131.42M

现金及等价物

USD 90.85M

USD 1.35M

USD 126.33M

USD 117.3M

USD 299.23M

股息收益率

0

USD -26.76M

USD -26.2M

325

EPS每股收益

USD -1.02

股本和储备

USD -265.65M

USD 33.72M

债务利息支出

USD 12.55M

USD -0.15

USD 264.49M

USD 10.2M

USD -22.39M

USD 61.83M

USD -26.76M

普通股股本

USD 22.54M

USD -22.39M

USD 35.07M

销售和管理费用

USD 10.42M

USD 4.04M

贸易债权人

USD 4.28M

应收帐款人

USD 23.36M

	流动负债	更改		日
AbbVie	USD 43.1B		1.46B	2026-09
Abbott	USD 16.15B		1.66B	2026-09
Amgen	USD 23.23B		2.27B	2026-09
AstraZeneca	USD 31.27B		286M	2026-09
BioCryst Pharmaceuticals	USD 195.83M		13.02M	2026-09
Bristol-Myers Squibb	USD 18.75B		94M	2026-09
Eli Lilly	USD 47B		745M	2026-09
Enanta Pharmaceuticals	USD 44.73M		3.83M	2025-12
GlaxoSmithKline	GBP 20.72B		814M	2026-09
Incyte	USD 1.44B		125.72M	2026-09
J&J	USD 55.46B		562M	2026-09
Karyopharm Therapeutics	USD 117.3M		25.24M	2026-03
MacroGenics	USD 108.82M		12.88M	2026-06
Merck	USD 28.8B		1.07B	2026-09
Nektar Therapeutics	USD 57.71M		4.17M	2026-03
Novartis	USD 32.52B		777M	2026-09
Novartis	USD 32.52B		1.15B	2026-09
Pfizer	USD 31.73B		920M	2026-09
Regeneron Pharmaceuticals	USD 6.2B		671.5M	2026-09
Roche Holding	CHF 28.85B		846M	2026-06
Sangamo BioSciences	USD 47.66M		1.9M	2025-06
Takeda	JPY 2.6T		161B	2026-09
Tectonic Therapeutic	USD 10.37M		2.59M	2026-06
TG Therapeutics	USD 268.49M		81.38M	2026-06
Ultragenyx Pharmaceutical	USD 389M		38M	2026-09
Xencor	USD 76.27M		5.6M	2026-09